about
Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancerHelicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillanceSystematic review with meta-analysis: the association between the use of calcium channel blockers and gastrointestinal bleedingIs non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patientsSmall bowel enteropathy associated with chronic low-dose aspirin therapySTROBE-Long-Term Exposure to Ambient Fine Particulate Air Pollution and Hospitalization Due to Peptic UlcersIdentification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer.Fecal viral load and norovirus-associated gastroenteritis.Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis.Pathogenesis of pre-neoplastic lesions of the stomach: targets for prevention.Inter-observer variations on interpretation of capsule endoscopies.Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer.Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer.Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell lineFibulin 1 is downregulated through promoter hypermethylation in gastric cancerThe association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies.Screening for gastric cancer in Asia: current evidence and practice.Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer.The Asia-Pacific consensus on ulcerative colitis.Developing the use of mismatch binding proteins for discovering rare somatic mutations.Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease Consensus--Part 1).Asia-Pacific consensus statements on Crohn's disease. Part 2: Management.Immunoglobulin G4-related disease in Hong Kong: clinical features, treatment practices, and its association with multisystem disease.Agranulocytosis in a drug addict with recurrent Staphylococcus aureus septicaemia.Effects of nucleoside analogue prescription for hepatitis B on the incidence of liver cancer in Hong Kong: a territory-wide ecological study.Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia.Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management.Empirical treatment based on "typical" reflux symptoms is inappropriate in a population with a high prevalence of Helicobacter pylori infection.Infection-related hospitalizations in the first year after inflammatory bowel disease diagnosis.4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone promoted gastric cancer growth through prostaglandin E receptor (EP2 and EP4) in vivo and in vitro.NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors.Association Between Acute Neuropsychiatric Events and Helicobacter pylori Therapy Containing Clarithromycin.Indoleamine 2,3-dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and is Associated with Type II Hypersensitivity/Autoimmunity.Colorectal neoplasia in Asia: a multicenter colonoscopy survey in symptomatic patients.Anti-proliferative and pro-apoptotic effects of herbal medicine on hepatic stellate cell.Transmission of hepatitis B by human bite--confirmation by detection of virus in saliva and full genome sequencing.Expression of peroxisome proliferator-activated receptor delta in human gastric cancer and its response to specific COX-2 inhibitor.Anti-sense trefoil factor family-3 (intestinal trefoil factor) inhibits cell growth and induces chemosensitivity to adriamycin in human gastric cancer cells.Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2.
P50
Q24293304-A9FCC75D-B14C-4716-A24E-8A923D15DAA8Q26774447-2927C5B1-EEAF-424F-B8F9-6F32E13B6914Q28081521-C67F006D-7624-4CDB-A0FE-7652E574DC7DQ28181043-4CB5B26F-93EF-4C98-98E5-ADE0F59AB684Q28219150-9F86A14C-9297-4857-ADDC-18B9B9E1E52AQ28602946-38A11E20-0052-4D49-AD18-DFD93121D738Q33689057-9F3FD13E-3EA4-4AFD-AEA6-2C2319261031Q34199910-07FCBFBA-AFA8-47EC-8E5B-17FAF627AE58Q35793225-4D7BF5B8-32E6-4DE6-A021-3FEB317F7714Q36014000-1293B5A7-4389-47A1-BEF4-ADF2DA18B0DFQ36090018-2BF1347E-CDDA-4145-A836-6C14CD58218CQ36389221-8CD2CFE4-857D-4113-BAA8-4553AF45A5C9Q36616006-CC79517D-6FA4-4015-BED3-D1223A09BA83Q36622560-28E8EE9C-C094-458F-9ACA-3F21201F1224Q36695660-D586E7BF-F196-4171-8C7D-8A5C123484DEQ37023915-46E7E69F-7FFA-4C67-A846-DF2BB5E60369Q37030683-43EDE1E5-EF8A-4446-9D5D-957BA867B32DQ37097420-77E34430-FC71-4903-B842-EB6A047B51E5Q37330694-67CBB364-7141-47BE-90D7-71F86CC3C42DQ37725083-1AC72978-CEFB-494E-BC6C-5A926F01B3B1Q38328709-7537CB4A-13BA-4F7F-AF6F-228D3F9993AAQ38394640-03AD754F-DDC5-47B7-9DEA-96C8DF2EB72EQ38394726-F61D8417-D415-4E40-AE91-5414E42143A5Q38598244-0574BA4B-67A5-4052-9C0B-F6FAD5D13F5FQ38641561-835ECA3F-00B1-4EE5-A57D-3E87CF46B63BQ39099698-F0ACEE31-9675-408E-B417-BB1B74829FCCQ39160800-0320421D-5A76-4BC8-A562-F4ED2C34B769Q39217774-1B175F17-E299-4882-9DC9-EACE29103487Q39408759-3C88D2C6-335E-4DF0-8641-57B957152FF5Q39481675-654F2936-D8CE-43DF-A80C-2F9D68B170E4Q39603837-637FDCE2-3E84-4FBB-9446-4CB85FE09EFCQ39631146-504E765D-07B8-4AD5-966B-9F60256CF07AQ39802868-5D8C2772-97F0-4EF0-A1C4-00B89BB5D211Q40045246-9EF9C5E4-39D6-48B1-A40C-A038E2E6C026Q40277031-14000602-775D-43D2-9FCA-452CFD1FBC80Q40410955-0CB4C35A-F035-4C08-9D4F-538930239000Q40420462-F1997D63-FC3D-454C-884C-F641F4C7D6FEQ40423550-014BF1FA-2EA3-41F2-AC5F-3E6286406506Q40446446-5AFA2E56-14CD-4D25-8E0E-DB052F002A70Q40541428-F45595B3-F2FA-4EBD-9F6F-F8BF140C4B6E
P50
description
researcher
@en
wetenschapper
@nl
name
W K Leung
@en
W K Leung
@nl
type
label
W K Leung
@en
W K Leung
@nl
prefLabel
W K Leung
@en
W K Leung
@nl
P108
P106
P31
P496
0000-0002-5993-1059